Biotest AG (ETR:BIO)

PRESS RELEASE

published on 02/28/2024 at 10:00, 2 years ago

Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care
Prof Dr Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne, emphasizing vital contribution to patient care. Plasma donation in Germany crucial for medical supply

Germany Patient Care Biotest AG Karl Lauterbach Plasma Donation
BRIEF

published on 02/28/2024 at 10:00, 2 years ago

Visit of Karl Lauterbach to the plasma donation center of Biotest AG in Cologne

Germany Biotest AG Karl Lauterbach Plasma Donation Medical Care
PRESS RELEASE

published on 02/14/2024 at 08:30, 2 years 1 month ago

Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential

Biotest AG Fibrinogen Concentrate Phase III Trial Study Results Medical Market Potential
PRESS RELEASE

published on 11/28/2023 at 09:00, 2 years 3 months ago

EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
PRESS RELEASE

published on 11/02/2023 at 08:00, 2 years 4 months ago

Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
PRESS RELEASE

published on 10/05/2023 at 16:55, 2 years 5 months ago

EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
PRESS RELEASE

published on 10/05/2023 at 16:42, 2 years 5 months ago

EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
PRESS RELEASE

published on 09/21/2023 at 09:00, 2 years 5 months ago

Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK
PRESS RELEASE

published on 09/12/2023 at 09:00, 2 years 6 months ago

Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
PRESS RELEASE

published on 09/07/2023 at 09:00, 2 years 6 months ago

Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo

Published on 03/16/2026 at 22:45, 45 minutes ago

Copper Road Announces Closing of Financing
Published on 03/16/2026 at 22:30, 1 hour ago

Core Silver Intersects High-Grade Copper-Molybdenum Veins up to 7.31% Cu & 1.01% Mo Confirming Large Porphyry System at Laverdiere
Published on 03/16/2026 at 22:00, 1 hour 30 minutes ago

Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19
Published on 03/16/2026 at 21:30, 2 hours ago

Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Published on 03/16/2026 at 21:00, 2 hours 30 minutes ago

Amdocs Brings AI-Accelerated Application Modernization to Enterprises with NVIDIA

View all ACCESSWIRE

Published on 03/16/2026 at 23:07, 22 minutes ago

KION brings physical AI into live warehouse operations at GTC 2026 in San José, California
Published on 03/16/2026 at 22:35, 54 minutes ago

Nscale and Microsoft Announce Collaboration with NVIDIA and Caterpillar to Deliver 1.35GW of NVIDIA Vera Rubin NVL72 GPUs at Flagship AI Factory Campus in West Virginia
Published on 03/16/2026 at 22:25, 1 hour 4 minutes ago

Nscale Acquires American Intelligence & Power Corporation, Creating a Full Stack AI Hyperscaler, Integrated from Energy to Compute
Published on 03/16/2026 at 21:35, 1 hour 54 minutes ago

WEKA Maximizes Token Output With Lower Cost Per Token on NVIDIA BlueField-4 STX
Published on 03/16/2026 at 21:35, 1 hour 54 minutes ago

WEKA Accelerates AI Factory Deployment Times From Months to Minutes with Turnkey NVIDIA AI Data Platform Solution

View all EQS

Published on 03/16/2026 at 18:00, 5 hours 30 minutes ago

Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 5 hours 32 minutes ago

Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 5 hours 33 minutes ago

Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:45, 5 hours 45 minutes ago

Weekly share buyback
Published on 03/16/2026 at 17:35, 5 hours 55 minutes ago

Disclosure of transactions in own shares from March 9 to March 13, 2026

View all LES ECHOS COMFI WIRE

News